long-term effects of glp-1 medications Your guide to side Adverse Effects of GLP-1 Receptor

November 14, 2024

Studies have examined retatrutide in preclinical and clinical settings involving GLP-1, GIP, and glucagon receptor signaling and downstream metabolic endpoints

Mol Metab 2022;63:101533.ArticlePubMedPMC 61

Alnylam and regeneron report positive interim phase 1 clinical data on ALN-APP, an investigational RNAi therapeutic for Alzheimers disease and cerebral amyloid angiopathy

Jost, C., Nitsche, C., Scholz, T., Roux, L

Astragaloside IV, a primary active compound in Astragalus membranaceus , has demonstrated cardioprotective effects through mechanisms such as antioxidant, anti-inflammatory, and anti-apoptotic activities